FIRST TR EXCHANGE TRADED FD - INDXX GBL MED (MDEV)

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / INDXX GBL MED
Total 13F shares
56,970
Share change
-2,773
Total reported value
$1,069,504
Price per share
$18.78
Number of holders
8
Value change
-$52,077
Number of buys
3
Number of sells
2

Institutional Holders of FIRST TR EXCHANGE TRADED FD - INDXX GBL MED (MDEV) as of Q4 2022

As of 31 Dec 2022, FIRST TR EXCHANGE TRADED FD - INDXX GBL MED (MDEV) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,970 shares. The largest 8 holders included JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, Baker Avenue Asset Management, LP, ADVISOR GROUP HOLDINGS, INC., J Arnold Wealth Management Co, UBS Group AG, HARBOUR INVESTMENTS, INC., and SRS Capital Advisors, Inc.. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.